Aptar Pharma is proud to have won two InnoPack 2022 China Awards recently, in recognition of our HeroTracker® Sense and Activ-Blister™ solutions.
HeroTracker® Sense by Aptar Digital Health was announced Gold Winner in the InnoPack 2022 China Awards’ Patient Adherence category. HeroTracker® Sense is a novel digital respiratory health solution that transforms a standard metered dose inhaler (pMDI) into a smart connected healthcare device, allowing patients living with respiratory conditions to track and monitor their disease management.
“We are really pleased to receive this award. We see HeroTracker® Sense as a product for the future, and one that will demonstrate significant value, creating real world evidence that can aid the support of reimbursement models in numerous different markets,” said Sai Shankar, President, Aptar Digital Health.
Aptar CSP’s Activ-Blister™ solutions, which was named Silver Winner in the Market Potential category of the Innopack 2022 China Awards, offers a new way to address drug product stability concerns for oral solid doses and capsule-based dry powder inhalers, extending shelf life and ensuring the efficacy of the drug product. The technology embeds the company’s patented 3-Phase Activ-Polymer™ film into individual blister cavities to create a custom-formulated microclimate around each dose to meet specific drug long-term and in-use stability requirements while maintaining therapeutic efficacy. Outfitted blisters can adsorb tailored amounts of moisture, scavenge oxygen, odors, or VOCs, emit aromas, or provide a combination of active protection.
Badre Hammond, Vice-President, Commercial Operations and GM, APAC, Aptar CSP Technologies, said, “At Aptar CSP, we believe that innovation start with patients and consumers in mind. Activ-Blister™ solutions creates a microclimate within the headspace of each pill or tablet ensuring stable and efficacious treatment from R&D to the pharmacy shelf.”
InnoPack China, part of CPhI & P-MEC China, announced the winners of the Innopack China 2022 Awards on December 20, 2022. An official awards ceremony is planned to take place later in 2023.